Pessano Sara, Boldor Maria, Faravelli Francesca, Fiander Michelle, Jørgensen Karsten Juhl, Soll Roger F, Bruschettini Matteo
Scientific Direction, Clinical Epidemiology Unit, IRCCS Istituto Giannina Gaslini, Genova, Italy.
Department of Public Health, Experimental and Forensic Medicine, Unit of Biostatistics and Clinical Epidemiology, Medical Statistics and Biometry Postgraduate School, Pavia, Italy.
Cochrane Database Syst Rev. 2025 Apr 7;4(4):CD016118. doi: 10.1002/14651858.CD016118.
This is a protocol for a Cochrane Review (intervention). The objectives are as follows: To evaluate the benefits and harms of using NGS techniques compared to conventional newborn screening alone for pre-symptomatic identification of genetic diseases in newborns.
to explore equity and ethical issues in the application of the new techniques, to inform healthcare decisions by families, carers, and policymakers.
这是一项Cochrane系统评价(干预性研究)的方案。目标如下:评估与单纯使用传统新生儿筛查相比,采用二代测序(NGS)技术对新生儿进行症状前遗传疾病鉴定的益处和危害。
探讨新技术应用中的公平性和伦理问题,为家庭、护理人员及政策制定者的医疗决策提供依据。